Schedule 13G ownership disclosure

Arcutis Biotherapeutics Inc

Security class unavailable · CUSIP: 03969K108

Event date: Unavailable

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
9,650,811
Percent of class
Unavailable

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001137774-23-000119
Form type
SC 13G
Filer
Arcutis Biotherapeutics, Inc.
CIK
CIK 1787306
Filed
Nov 09, 2023
Reporting period
—
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub